ATP2A2 and cardiomyopathy: The expression of serca2, another therapeutic target for cardiomyopathy, was decreased significantly (0.7 ± 0.17-fold) during 2 day of ER stress induction in mice as compared with 8 h (1.15 ± 0.06-fold) and control mice (Fig. 5B).